Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer

Partial thyrocyte-specific Gαs deficiency leads to rapid-onset hypothyroidism, hyperplasia, and papillary thyroid carcinoma–like lesions in mice

(2018) Konrad Patyra et al.   FASEB JOURNAL

CD97/ADGRE5 Inhibits LPS Induced NF-κB Activation through PPAR-γUpregulation in Macrophages

(2016) Shuai Wang et al.   MEDIATORS OF INFLAMMATION

Thyrotropin and Insulin-Like Growth Factor 1 Receptor Crosstalk Upregulates Sodium–Iodide Symporter Expression in Primary Cultures of Human Thyrocytes

(2016) Sarah J. Morgan et al.   THYROID

Targeted therapies in thyroid cancer: an extensive review of the literature

(2016) Athanasios Bikas et al.   Expert Review of Clinical Pharmacology

Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression

(2015) Luchuan Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis

(2015) G. Riesco-Eizaguirre et al.   CANCER RESEARCH

Targeted therapies in advanced differentiated thyroid cancer

(2015) Raquel M. Carneiro et al.   CANCER TREATMENT REVIEWS

New Therapies for Dedifferentiated Papillary Thyroid Cancer

(2015) Poupak Fallahi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inverse Agonist of Estrogen-Related Receptor   Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells

(2015) T. D. Singh et al.   JOURNAL OF NUCLEAR MEDICINE

TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer

(2015) Francesca Coperchini et al.   TUMOR BIOLOGY

Codon-optimized Human Sodium Iodide Symporter (opt-hNIS) as a Sensitive Reporter and Efficient Therapeutic Gene

(2015) Young-Hwa Kim et al.   Theranostics

Molecular Targeted Therapies of Aggressive Thyroid Cancer

(2015) Silvia Martina Ferrari et al.   Frontiers in Endocrinology

Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets

(2014) Christine Spitzweg et al.   Lancet Diabetes & Endocrinology

Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy

(2013) H V Reddi et al.   CANCER GENE THERAPY

Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules?

(2013) Shuhang Xu et al.   JOURNAL OF ENDOCRINOLOGY

In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma

(2013) J.J. Dong et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth

(2013) X.-M. Yu et al.   MOLECULAR CANCER THERAPEUTICS

Re-induction of cell differentiation and 131I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection

(2012) Fang Feng et al.   NUCLEAR MEDICINE AND BIOLOGY

Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line

(2012) Hyun-Jeung Choi et al.   NUCLEAR MEDICINE AND BIOLOGY

CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model

(2012) Y Ward et al.   ONCOGENE

LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells

(2011) Y. Ward et al.   CANCER RESEARCH

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

(2011) A. T. Franco et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

(2010) M. Hingorani et al.   CURRENT CANCER DRUG TARGETS

Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activityin Vitroandin Vivoin Papillary Dedifferentiated Thyroid Cancer

(2010) Alessandro Antonelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo

(2009) Matteo Landriscina et al.   PROSTATE

Nevirapine Toxicity in Non-HIV Cancer Patients

(2008) Matteo Landriscina et al.   CHEMOTHERAPY

Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests

(2008) Alessandro Antonelli et al.   CLINICAL ENDOCRINOLOGY

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

(2008) Rebecca E. Schweppe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM